
	Home Site Map Contact Links Medical News

antegren and the fda

Find antegren
Looking for antegren? Review and compare FindStuff's comprehensive resources.
Find antegren
Looking for antegren? Review and compare FindStuff's comprehensive resources.
antegren
Compare Prices on antegren and More.Get the Best Deal at BottomDollar.com!
antegren Info
Get Info on antegren from 14 search engines in 1.
Find antegren.
Looking for antegren? Review and compare FindStuff's comprehensive resources. Search now!
Antegren Find the Best Deals
Compare Prices on Antegren and More. Get the Best Deal at BottomDollar!
antegren
Discount antegren - Compare Online and Save!
Find antegren.
Looking for antegren? Review and compare FindStuff's comprehensive resources. Search now!
The Best Online Deals for antegren
Find the Best Deals Here. Shop for antegren now.
Looking For antegren.
Helpful Links for antegren.

antegren and the fda
Biogen Idec and Elan Announce Intention to Submit for Approval for Multiple SclerosisBased on One-Year Data

CAMBRIDGE, Mass antegren and the fda. & SAN DIEGO & DUBLIN, Ireland--February 18, 2004--BiogenIdec and Elan Corporation, plc today announced that they expect to submit tothe U.S antegren and the fda. Food and Drug Administration (FDA) an application for approval of Antegren(natalizumab) as a treatment for multiple sclerosis (MS) antegren and the fda. The companies expectto submit the filing mid-year 2004.

The decision to file a Biologics License Application (BLA) was made after discussionswith the FDA of one-year data from the two ongoing two-year Phase III trialsin MS antegren and the fda. The companies are committed to completing the two-year trials antegren and the fda. To protectthe integrity of the trials, the companies are not disclosing the one-year dataat this time.

Biogen Idec and Elan are collaborating equally on the development of natalizumabfor MS, Crohn's disease, and rheumatoid arthritis.

About the Antegren MS Clinical Trials
The AFFIRM (natalizumab safety and efficacy in relapsing-remitting MS) trialis a two-year, randomized, multi-center, placebo-controlled, double-blind studyof approximately 900 patients, evaluating the ability of natalizumab to slowthe progression of disability in MS and reduce the rate of clinical relapses antegren and the fda. The SENTINEL (safety and efficacy of natalizumab in combination with Avonex(Interferon beta-1a)) trial is a two-year, randomized, multi-center, placebo-controlled,double-blind study of approximately 1,200 patients with relapsing-remittingMS, evaluating the effect of the combination of natalizumab and Avonex comparedto treatment with Avonex alone in slowing the progression of disability andreducing the rate of clinical relapses antegren and the fda. Both studies have protocols that includeda one-year analysis of the data antegren and the fda. The primary endpoints for both Phase III two-yeartrials in MS are based on the Expanded Disability Status Scale (EDSS) and relapserates antegren and the fda. The pre-specified primary endpoint of the one-year analysis was relapserates.

About Antegren (natalizumab)
Natalizumab, a humanized monoclonal antibody, is the first alpha-4 antagonistin the new SAM (selective adhesion molecule) inhibitor class antegren and the fda. The drug was designedto selectively inhibit immune cells from leaving the bloodstream and to preventthese cells from migrating into chronically inflamed tissue as occurs in a varietyof inflammatory diseases antegren and the fda. To date, approximately 2,800 patients have receivednatalizumab in clinical studies antegren and the fda. In previous clinical trials, the followingadverse events occurred more commonly with natalizumab when compared to placebo:headache, nausea, abdominal pain, infection, urinary tract infection, pharyngitisand rash antegren and the fda. Serious adverse events have included infrequent hypersensitivity-likereactions.

antegren fda antegren ms antegren or antigrin new news on antegren antegren and the fda antegren malaga crohn antegren side effects potential problems with antegren how to take antegren antegren ms antegren sentinel study side effects antegren antegren therapy antegren results antegren rumors antegren natalizumab side effects antegren logo how to take antegren antegren and ms antegren fda antegren and multiple sclerosis antegren ms antegren rumors antegren news antegren news potential problems with antegren antegren jama fda antegren ruling antegren or antigrin antegren logo antegren experience antegren multiple sclerosis antegren updates antegren and the fda antegren sentinel study new news on antegren antegren news biogen antegren crohn antegren side effects antegren side effects antegren and multiple sclerosis antegren jama antegren and administer antegren experience antegren therapy antegren logo antegren cause rise in alt fda antegren ruling antegren and administer antegren and multiple sclerosis antegren and multiple sclerosis antegren antegren price antegren or antigrin antegren sentinel study biogen antegren antegren and multiple sclerosis antegren side effects antegren antegren ms antegren fda approval antegren has approved new news on antegren antegren results antegren fda approval new news on antegren antegren and multiple sclerosis antegren fda approval

abilify abraxane accolate accupril accutane acetaminophen aciphex aclovate actifed activase actiza actonel actos aczone adacel adalat adderall adipex advair advate agilect albalon albuterol aldomet alesse aleve alimta allegra aloxi alphagan alprazolam altace altocor alvesco amaryl ambien amiodarone amitriptyline amoxicillin androgel angeliq anidulafungin antabuse antegren anusol apidra apokyn arthrotec asacol aspirin atenolol ativan augmentin avandia avapro avastin avelox axid

aantegren and the fda anntegren and the fda anttegren and the fda anteegren and the fda anteggren and the fda antegrren and the fda antegreen and the fda antegrenn and the fda antegren and the fda antegren aand the fda antegren annd the fda antegren andd the fda antegren and the fda antegren and tthe fda antegren and thhe fda antegren and thee fda antegren and the fda antegren and the ffda antegren and the fdda antegren and the fdaa ntegren and the fda ategren and the fda anegren and the fda antgren and the fda anteren and the fda antegen and the fda antegrn and the fda antegre and the fda antegrenand the fda antegren nd the fda antegren ad the fda antegren an the fda antegren andthe fda antegren and he fda antegren and te fda antegren and th fda antegren and thefda antegren and the da antegren and the fa antegren and the fd a ntegren and the fda an tegren and the fda ant egren and the fda ante gren and the fda anteg ren and the fda antegr en and the fda antegre n and the fda antegren and the fda antegren and the fda antegren a nd the fda antegren an d the fda antegren and the fda antegren and the fda antegren and t he fda antegren and th e fda antegren and the fda antegren and the fda antegren and the f da antegren and the fd a antegren and the fda nategren and the fda atnegren and the fda anetgren and the fda antgeren and the fda antergen and the fda antegern and the fda antegrne and the fda antegre nand the fda antegrena nd the fda antegren nad the fda antegren adn the fda antegren an dthe fda antegren andt he fda antegren and hte fda antegren and teh fda antegren and th efda antegren and thef da antegren and the dfa antegren and the fad aantegren and the fda theantegren and the fda antegren and the fda

a b c d e f g h i k l m n o p r s t u v w x z